BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 24443320)

  • 1. A rapid DNA extraction method suitable for human papillomavirus detection.
    Brestovac B; Wong ME; Costantino PS; Groth D
    J Med Virol; 2014 Apr; 86(4):653-7. PubMed ID: 24443320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The performance of human papillomavirus DNA detection with type 16/18 genotyping by hybrid capture in primary test of cervical cancer screening: a cross-sectional study in 10,669 Chinese women.
    Zhao X; Wu Q; Wang X; Fu Y; Zhang X; Tian X; Cheng B; Lu B; Yu X; Lan S; Lu W; Ma D; Cheng X; Xie X
    Clin Microbiol Infect; 2018 Dec; 24(12):1322-1327. PubMed ID: 29518562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical performances of the AdvanSure HPV Screening Real-Time PCR, the Abbott Real-Time High-Risk HPV Test, and the Hybrid Capture High-Risk HPV DNA Test for Cervical Cancer Screening.
    Chung HS; Hahm C; Lee M
    J Virol Methods; 2014 Sep; 205():57-60. PubMed ID: 24814874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening.
    Chatzistamatiou K; Moysiadis T; Moschaki V; Panteleris N; Agorastos T
    Gynecol Oncol; 2016 Jul; 142(1):120-127. PubMed ID: 27126005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Enhanced molecular techniques for the diagnosis of human papillomavirus infections].
    Ursu RG; Onofriescu M; Nemescu D; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1205-10. PubMed ID: 20191900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year longitudinal data on the clinical performance of the Abbott RealTime High Risk HPV test in a cervical cancer screening setting.
    Poljak M; Oštrbenk A; Seme K; Šterbenc A; Jančar N; Vrtačnik Bokal E
    J Clin Virol; 2016 Mar; 76 Suppl 1():S29-S39. PubMed ID: 26643051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.
    Aoyama-Kikawa S; Fujita H; Hanley SJB; Kasamo M; Kikuchi K; Torigoe T; Matsuno Y; Tamakoshi A; Sasaki T; Matsuura M; Kato Y; Dong P; Watari H; Saito T; Sengoku K; Sakuragi N
    Cancer Sci; 2018 Jun; 109(6):2003-2012. PubMed ID: 29660849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus types 16 and 18 mRNA levels and not DNA levels may be associated with advancing stages of cervical cancer.
    Gnanamony M; Peedicayil A; Subhashini J; Ram TS; Christopher S; Gravitt P; Abraham P
    Int J Gynecol Cancer; 2009 Nov; 19(8):1415-20. PubMed ID: 20009900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.
    Kailash U; Soundararajan CC; Lakshmy R; Arora R; Vivekanandhan S; Das BC
    Br J Cancer; 2006 Nov; 95(9):1250-7. PubMed ID: 17060942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the management of Hr-HPV+/PapTest- women: results at 1-year recall.
    Chiappetta C; Puggioni C; Lendaro E; Cacciotti J; Zaralli R; Migliore G; Bellardini P; Petrozza V; Della Rocca C; Di Cristofano C
    Int J Clin Exp Pathol; 2015; 8(12):16089-96. PubMed ID: 26884886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Performance of human papillomavirus typing test in cervical precancer lesions and cervical cancer screening].
    Zhang SK; Luo XP; Li ZF; Su Z; Xia JC; Hu GY; Zhu YJ; Xie LX; Feng XX; Sun XB; Chen W; Qiao YL
    Zhonghua Zhong Liu Za Zhi; 2020 Mar; 42(3):252-256. PubMed ID: 32252206
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the effectiveness of BMRT-HPV for cervical cancer screening].
    Duan LF; Du H; Wang C; Huang X; Qu XF; Duan XZ; Liu Y; Shi B; Zhang W; Wei LH; Belinson L; Wu RF
    Zhonghua Fu Chan Ke Za Zhi; 2020 Oct; 55(10):708-715. PubMed ID: 33120484
    [No Abstract]   [Full Text] [Related]  

  • 14. CIN2+ detection of the HPV DNA Array genotyping assay in comparison with the Cobas 4800 HPV test and cytology.
    Pesic A; Krings A; Hempel M; Preyer R; Chatzistamatiou K; Agorastos T; Kaufmann AM
    Virol J; 2019 Jul; 16(1):92. PubMed ID: 31337408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of human papillomavirus types in women from Valencia, Spain, with abnormal cytology.
    Garcia-García JA; Pérez-Vallés A; Martorell M; Gómez B; Gómez-Cabrero D; Soler F; Calabuig C
    Acta Cytol; 2010; 54(2):159-64. PubMed ID: 20391971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus testing for suspected cervical cancer patients from Southern Assam by fast-PCR.
    Ghosh SK; Choudhury B; Hansa J; Mondal R; Singh M; Singh M; Duttagupta S; Das A; Kumar R; Laskar RS; Kannan R; Ghosh PR
    Asian Pac J Cancer Prev; 2011; 12(3):749-51. PubMed ID: 21627377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and genotyping of high risk human papillomavirus in cervical cancer samples from Punjab, Pakistan.
    Siddiqa A; Zainab M; Qadri I; Bhatti MF; Parish JL
    Viruses; 2014 Jul; 6(7):2762-77. PubMed ID: 25036463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous detection of human papillomavirus integration and c-MYC gene amplification in cervical lesions: an emerging marker for the risk to progression.
    Gimenes F; Souza RP; de Abreu AL; Pereira MW; Consolaro ME; da Silva VR
    Arch Gynecol Obstet; 2016 Apr; 293(4):857-63. PubMed ID: 26315473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Cobas 4800 Human Papillomavirus test against a combination of the Amplicor Human Papillomavirus and the Linear Array tests for detection of HPV types 16 and 18 in cervical samples.
    Martínez SB; Palomares JC; Artura A; Parra M; Cabezas JL; Romo JM; Martín-Mazuelos E
    J Virol Methods; 2012 Mar; 180(1-2):7-10. PubMed ID: 22197189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening.
    Tay SK; Lin LE; Goh RC
    Ann Acad Med Singap; 2017 Jul; 46(7):267-273. PubMed ID: 28821890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.